Purchase Order HHSN268201600024A
Award Date 12/1/15
Potential Completion Date 11/30/17
Potential Value $204K
Federal Agency
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $17,118.00 firm fixed price purchase order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) to provide a service contract to maintain a flow cytometer. The contract period of performance is June 2, 2025 through June 1, 2026. No set-aside designation was used for this award. BD is a global medical technology company that develops, manufactures, and sells medical devices,...
- This is a firm fixed-price service contract awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) for the maintenance of a Fortessa X-20 flow cytometry instrument. The contract period is from August 18, 2017, to August 17, 2018, with a ceiling value of $24,047.88. BD, a global medical technology company, is the prime contractor for this contract, which does not have a small business...
- The National Heart Lung and Blood Institute awarded a purchase order to Becton, Dickinson and Company (BD Biosciences) for an LSRFortessa multi-year maintenance agreement with a ceiling value of $283,987.80, awarded November 17, 2014, with ultimate completion November 20, 2019. Place of performance is Bethesda, Maryland. The order is firm fixed price with no set-aside. This is a maintenance agreement supporting flow cytometry instrumentation at a federal research facility, typical of BD...
- This is a firm fixed-price purchase order contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) through its BDB Division and BD Biosciences brand. The $21,900.48 contract is for a service contract to maintain the NHLBI's FACS Fortessa X-20 SORP flow cytometry instrument. This contract does not have a set-aside designation, indicating it was competed on a full and open basis. BD, a...
- The National Heart Lung and Blood Institute awarded a purchase order to Becton, Dickinson and Company (BD Biosciences) for $29,795.40 on January 23, 2019, for a maintenance agreement with an ultimate completion date of January 31, 2020. Work is performed at Bethesda, Maryland. The order is firm fixed price with no small business set-aside applied. The maintenance agreement supports BD flow cytometry instrumentation operated by the Institute, consistent with BD Biosciences' established supplier...
- This firm fixed price purchase order was awarded by the National Heart Lung and Blood Institute, a civilian agency of the U.S. government, to Becton, Dickinson and Company (BD) for LSRFortessa maintenance services. The $219,675 contract has a ceiling value and a performance period ending on September 30, 2025. The award does not utilize a set-aside designation. BD, a global medical technology company, will provide maintenance services for the agency's LSRFortessa instruments, which are...
- This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) for a maintenance agreement covering a BD LSR II flow cytometer with lasers and computer. The contract has a ceiling value of $20,628 and a completion date of November 17, 2014. BD is a global medical technology company that provides instruments, reagents, and services for biomedical research...
- Becton, Dickinson and Company's BD Biosciences division was awarded a $201,042 firm fixed-price purchase order by the National Heart Lung and Blood Institute (NHLBI) on April 1, 2025, for the Service Agreement Symphony A3 and Lasers. The contract, which operates without a small business set-aside, has an ultimate completion date of March 31, 2030, and will be performed in Bethesda, Maryland. Based on BD Biosciences' established federal contract portfolio, this award likely encompasses...
- <p>The National Heart Lung and Blood Institute awarded a purchase order to Becton, Dickinson And Company (BD Biosciences division) on December 20, 2016, with a ceiling value of $29,795.40 for maintenance services. The order is firm fixed price with no set-aside. Place of performance is Bethesda, Maryland. Ultimate completion date is January 31, 2018.</p>
- This federal contract award was made by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health, to Becton, Dickinson and Company (BD) to provide delivery of products and services. The $126,191.52 fixed-price delivery order contract has a period of performance through January 31, 2021 and was not set aside for any specific business category. BD is a global medical technology company that provides instruments, reagents, and services to support...